Sharon Tetlow - 14 Sep 2021 Form 4 Insider Report for DICE Therapeutics, Inc.

Role: Director
Signature: /s/ Scott Robertson as attorney-in-fact for Sharon Tetlow
Issuer symbol: N/A
Transactions as of: 14 Sep 2021
Net transactions value: $0
Form type: 4
Filing time: 16 Sep 2021, 21:28:59 UTC
Previous filing: 02 Jul 2021
Next filing: 08 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DICE	Common Stock						49,841	14 Sep 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DICE	Stock Option (right to buy)	Award	$0	+12,096		$0.000000	12,096	14 Sep 2021	Common Stock	12,096	$17.00	Direct	F3
transaction	DICE	Stock Option (right to buy)	Award	$0	+8,261		$0.000000	8,261	14 Sep 2021	Common Stock	8,261	$17.00	Direct	F4
transaction	DICE	Stock Option (right to buy)	Award	$0	+8,200		$0.000000	8,200	14 Sep 2021	Common Stock	8,200	$17.00	Direct	F5
transaction	DICE	Stock Option (right to buy)	Award	$0	+5,600		$0.000000	5,600	14 Sep 2021	Common Stock	5,600	$17.00	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The number of shares of Common Stock reported in the Reporting Holder's Form 3 reflected the conversion of derivative securities based on the midpoint of the Issuer's initial public offering range of $16.00 per share. The number of shares of Common Stock reflected in this Form 4 reflects the adjusted number of shares issued based on the higher initial public offering price of $17.00 per share, and does not reflect a disposition of shares.
F2	Certain of the shares are subject to the Issuer's right of repurchase if underlying vesting conditions are not met.
F3	The option vests as to 1/36th of the total shares monthly, beginning November 8, 2020, subject to the Reporting Holder's continued service to the Registrant.
F4	The option vests as to 1/36th of the total shares monthly, beginning January 1, 2021, subject to the Reporting Holder's continued service to the Registrant.
F5	The option vests as to 1/48th of the total shares monthly, beginning August 20, 2021, subject to the Reporting Holder's continued service to the Registrant.